abnormal seizure response to pharmacological agent_Szs5<DBA/2J>/?

http://metadb.riken.jp/0000950IC57BL6JDBA2JSzs5DBA2JSzs5DBA2J

abnormal seizure response to pharmacological agent_Szs5<DBA/2J>/?

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• seizure susceptibility 5
  http://metadb.riken.jp/db/mgi_rdf/MGI:1345649

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Szs5<DBA/2J>/?

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Szs5<DBA/2J>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: C57BL/6J * DBA/2J

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• abnormal seizure response to pharmacological agent
  http://purl.obolibrary.org/obo/MP_0000950

文献

http://purl.org/net/cito/citesAsAuthority

• T N. Ferraro, et.al., Mapping loci for pentylenetetrazol-induced seizure susceptibility in mice., The Journal of neuroscience : the official journal of the Society for Neuroscience, 1999, 19
  http://rdf.ncbi.nlm.nih.gov/pubmed/10436030